{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T06:45:31Z","timestamp":1763016331408},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2000,2,1]],"date-time":"2000-02-01T00:00:00Z","timestamp":949363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,2,1]],"date-time":"2000-02-01T00:00:00Z","timestamp":949363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2000,2,1]]},"DOI":"10.1038\/sj.bmt.1702165","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T15:38:58Z","timestamp":1031153938000},"page":"411-417","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["The effect of the serotherapy regimen used and the marrow cell dose received on rejection, graft-versus-host disease and outcome following unrelated donor bone marrow transplantation for leukaemia"],"prefix":"10.1038","volume":"25","author":[{"given":"JL","family":"Byrne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Stainer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Cull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AP","family":"Haynes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"EM","family":"Bessell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Hale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Waldmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NH","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2000,3,9]]},"reference":[{"key":"BF1702165_CR1","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1200\/JCO.1983.1.9.517","volume":"1","author":"E Thomas","year":"1983","unstructured":"Thomas E . Marrow transplantation for malignant diseases J Clin Oncol 1983 1: 517\u2013521","journal-title":"J Clin Oncol"},{"key":"BF1702165_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.7326\/0003-4819-104-2-155","volume":"104","author":"E Thomas","year":"1986","unstructured":"Thomas E, Clift R, Fefer A et al. Marrow transplantation for the treatment of chronic myelogenous leukemia Ann Intern Med 1986 104: 155\u2013163","journal-title":"Ann Intern Med"},{"key":"BF1702165_CR3","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1056\/NEJM198601233140403","volume":"314","author":"J Goldman","year":"1986","unstructured":"Goldman J, Apperley J, Jones L et al. Bone marrow transplantation for patients with chronic myeloid leukemia New Engl J Med 1986 314: 202\u2013207","journal-title":"New Engl J Med"},{"key":"BF1702165_CR4","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1097\/00007890-199510270-00003","volume":"52","author":"P Beatty","year":"1995","unstructured":"Beatty P, Dahlberg S, Milford E . Impact of racial genetic polymorphism on the probability of finding an HLA-matched donor Transplantation 1995 52: 778\u2013782","journal-title":"Transplantation"},{"key":"BF1702165_CR5","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1182\/blood.V84.9.2833.2833","volume":"84","author":"Committee Goldman J for the WMDA Executive","year":"1994","unstructured":"Goldman J for the WMDA Executive Committee . A special report: bone marrow transplants using volunteer donors \u2013 recommendations and requirements for a standardised practice throughout the world \u2013 1994 update Blood 1994 84: 2833\u20132839","journal-title":"Blood"},{"key":"BF1702165_CR6","first-page":"287","volume":"4","author":"P Beatty","year":"1985","unstructured":"Beatty P, Ash R, Hows J, McGlave P . The use of unrelated bone marrow donors in the treatment of patients with chronic myelogenous leukemia: experience of four marrow transplant centres Bone Marrow Transplant 1985 4: 287\u2013290","journal-title":"Bone Marrow Transplant"},{"key":"BF1702165_CR7","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1182\/blood.V75.8.1728.1728","volume":"75","author":"P McGlave","year":"1990","unstructured":"McGlave P, Beatty P, Ash R, Hows J . Therapy for chronic myelogenous leukemia with unrelated donor bone marrow transplantation: results in 102 cases Blood 1990 75: 1728\u20131732","journal-title":"Blood"},{"key":"BF1702165_CR8","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1182\/blood.V83.11.3409.3409","volume":"83","author":"S Mackinnon","year":"1994","unstructured":"Mackinnon S, Barnett L, Heller G, Or J . Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukaemia Blood 1994 83: 3409\u20133416","journal-title":"Blood"},{"key":"BF1702165_CR9","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1182\/blood.V81.2.543.543","volume":"81","author":"P McGlave","year":"1993","unstructured":"McGlave P, Barrsch G, Anasetti C et al. Unrelated donor transplantation therapy for chronic myeloid leukemia: initial experience of the National Bone Marrow Donor Program Blood 1993 81: 543\u2013550","journal-title":"Blood"},{"key":"BF1702165_CR10","doi-asserted-by":"publisher","first-page":"207","DOI":"10.7326\/0003-4819-119-3-199308010-00005","volume":"19","author":"D Marks","year":"1993","unstructured":"Marks D, Cullis J, Ward K et al. Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors: a comparison of complications in the first 2 years Ann Intern Med 1993 19: 207\u2013214","journal-title":"Ann Intern Med"},{"key":"BF1702165_CR11","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1056\/NEJM199804023381405","volume":"338","author":"J Hansen","year":"1998","unstructured":"Hansen J, Gooley T, Martin P et al. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia New Engl J Med 1998 338: 962\u2013968","journal-title":"New Engl J Med"},{"key":"BF1702165_CR12","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0955-3886(94)90134-1","volume":"15","author":"C Anasetti","year":"1994","unstructured":"Anasetti C, Hansen J . Effect of HLA incompatibility in marrow transplantation from unrelated and HLA-mismatched related donors Transfus Sci 1994 15: 221\u2013230","journal-title":"Transfus Sci"},{"key":"BF1702165_CR13","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1182\/blood.V86.4.1636.bloodjournal8641636","volume":"86","author":"S Davies","year":"1995","unstructured":"Davies S, Shu X, Blazar B et al. Unrelated donor bone marrow transplantation: influence of HLA-A and B incompatibility on outcome Blood 1995 86: 1636\u20131642","journal-title":"Blood"},{"key":"BF1702165_CR14","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1182\/blood.V86.4.1606.bloodjournal8641606","volume":"86","author":"E Petersdorf","year":"1995","unstructured":"Petersdorf E, Longton G, Anasetti C et al. The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation Blood 1995 86: 1606\u20131613","journal-title":"Blood"},{"key":"BF1702165_CR15","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1056\/NEJM199810223391701","volume":"339","author":"T Sazasuki","year":"1998","unstructured":"Sazasuki T, Takeo J, Morishima Y et al. Effect of matching class I alleles on clinical outcome after transplantation of hematopoietic cells from an unrelated donor New Engl J Med 1998 339: 1177\u20131185","journal-title":"New Engl J Med"},{"key":"BF1702165_CR16","first-page":"371","volume":"12","author":"J Hows","year":"1993","unstructured":"Hows J, Bradley B, Gore S et al. Prospective evaluation of unrelated donor bone marrow transplantation Bone Marrow Transplant 1993 12: 371\u2013380","journal-title":"Bone Marrow Transplant"},{"key":"BF1702165_CR17","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1182\/blood.V83.9.2392.2392","volume":"83","author":"SJ Forman","year":"1994","unstructured":"Forman SJ, Zaia JA . Treatment and prevention of cytomegalovirus pneumonia after bone marrow transplantation: where do we stand? Blood 1994 83: 2392\u20132398","journal-title":"Blood"},{"key":"BF1702165_CR18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/sj.bmt.1700637","volume":"19","author":"K Takenaka","year":"1997","unstructured":"Takenaka K, Gondo H, Yanimoto K et al. Increased incidence of cytomegalovirus (CMV) infection and CMV-associated disease after allogeneic bone marrow transplantation from unrelated donors Bone Marrow Transplant 1997 19: 241\u2013248","journal-title":"Bone Marrow Transplant"},{"key":"BF1702165_CR19","first-page":"1067","volume":"84","author":"J Goodrich","year":"1993","unstructured":"Goodrich J, Bowden R, Fisher L et al. Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic bone marrow transplant Ann Intern Med 1993 84: 1067\u20131071","journal-title":"Ann Intern Med"},{"key":"BF1702165_CR20","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1056\/NEJM199112053252303","volume":"325","author":"J Goodrich","year":"1991","unstructured":"Goodrich J, Mori M, Gleaves C et al. Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation New Engl J Med 1991 325: 1601\u20131607","journal-title":"New Engl J Med"},{"key":"BF1702165_CR21","first-page":"619","volume":"15","author":"O Ringden","year":"1995","unstructured":"Ringden O, Remberger M, Persson U et al. Similar incidence of graft-versus-host disease using HLA-A, B and DR identical unrelated bone marrow donors as with HLA-identical siblings Bone Marrow Transplant 1995 15: 619\u2013625","journal-title":"Bone Marrow Transplant"},{"key":"BF1702165_CR22","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Glucksberg","year":"1974","unstructured":"Glucksberg H, Storb R, Fefer A . Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors Transplant 1974 18: 295\u2013304","journal-title":"Transplant"},{"key":"BF1702165_CR23","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","volume":"69","author":"K Schulman","year":"1980","unstructured":"Schulman K, Sullivan KM, Weiden P . Chronic graft-versus-host disease in man: a long-term clinicopathologic study of 20 Seattle patients Am J Med 1980 69: 204\u2013217","journal-title":"Am J Med"},{"key":"BF1702165_CR24","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1182\/blood.V89.11.4226","volume":"89","author":"J Sierra","year":"1997","unstructured":"Sierra J, Storer B, Hansen J et al. Transplantation of marrow cells from unrelated donors for treatment of high risk acute leukaemia: the effect of leukaemic burden, donor HLA-matching and marrow cell dose Blood 1997 89: 4226\u20134235","journal-title":"Blood"},{"key":"BF1702165_CR25","first-page":"243","volume":"243","author":"R Clift","year":"1987","unstructured":"Clift R, Buckner C, Thomas E et al. The treatment of acute non-lymphoblastic leukemia by allogeneic marrow transplantation Bone Marrow Transplant 1987 243: 243\u2013248","journal-title":"Bone Marrow Transplant"},{"key":"BF1702165_CR26","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1001\/jama.1983.03330330044034","volume":"249","author":"M Bortin","year":"1983","unstructured":"Bortin M, Gale R, Kay H, Rimm A . Bone marrow transplantation for acute myelogenous leukaemia. Factors associated with early mortality JAMA 1983 249: 1166\u20131170","journal-title":"JAMA"},{"key":"BF1702165_CR27","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1056\/NEJM199303043280901","volume":"328","author":"NA Kernan","year":"1993","unstructured":"Kernan NA, Bartsch G, Ash RC et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program New Engl J Med 1993 328: 593\u2013602","journal-title":"New Engl J Med"},{"key":"BF1702165_CR28","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1182\/blood.V62.4.873.873","volume":"62","author":"G Hale","year":"1983","unstructured":"Hale G, Bright S, Chumbley G et al. Removal of T cells from bone marrow for transplantation: a monoclonal antilymphocyte antibody that fixes complement Blood 1983 62: 873\u2013882","journal-title":"Blood"},{"key":"BF1702165_CR29","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0140-6736(81)90647-4","volume":"2","author":"Y Reisner","year":"1981","unstructured":"Reisner Y, Kapoor N, Kirkpatrick D et al. Transplantation for acute leukaemia with HLA-A and B non-identical parental marrow cells fractionated with soybean agglutin and sheep red blood cells Lancet 1981 2: 327\u2013330","journal-title":"Lancet"},{"key":"BF1702165_CR30","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/S0140-6736(82)92619-8","volume":"1","author":"HG Prentice","year":"1982","unstructured":"Prentice HG, Blacklock H, Janossy G et al. Use of anti-T cell monoclonal antibody OKT3v to prevent acute graft-versus-host disease in allogeneic bone marrow transplantation for acute leukaemia Lancet 1982 1: 700\u2013703","journal-title":"Lancet"},{"key":"BF1702165_CR31","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/S0140-6736(84)92848-4","volume":"1","author":"H Prentice","year":"1984","unstructured":"Prentice H, Janossy G, Price-Jones L et al. Depletion of T lymphocytes in donor marrow prevents significant graft-versus-host disease in matched allogeneic leukaemic marrow recipients Lancet 1984 1: 472\u2013476","journal-title":"Lancet"},{"key":"BF1702165_CR32","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S0140-6736(84)92564-9","volume":"2","author":"H Waldmann","year":"1984","unstructured":"Waldmann H, Or R, Hale G et al. Elimination of graft-versus-host disease by in vitro depletion of alloreactive lymphocytes using a monoclonal rat anti-human lymphocyte antibody (CAMPATH 1) Lancet 1984 2: 483\u2013485","journal-title":"Lancet"},{"key":"BF1702165_CR33","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/00007890-198707000-00015","volume":"44","author":"A Filipovich","year":"1987","unstructured":"Filipovich A, Vallera D, Youle R et al. Graft-versus-host disease prevention in allogeneic bone marrow transplantation from histocompatible siblings. A pilot study using immunotoxins for T cell depletion of lymphocytes from human bone marrow Transplantation 1987 44: 62\u201369","journal-title":"Transplantation"},{"key":"BF1702165_CR34","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1097\/00007890-198743060-00014","volume":"43","author":"N Kernan","year":"1987","unstructured":"Kernan N, Flomenberg N, Dupont B, O'Reilly R . Graft rejection in recipients of T-cell depleted HLA-identical marrow transplants for leukaemia. Identification of host-derived anti-donor allocytotoxic T lymphocytes Transplantation 1987 43: 842\u2013846","journal-title":"Transplantation"},{"key":"BF1702165_CR35","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/00007890-198704000-00009","volume":"43","author":"D Bunjes","year":"1987","unstructured":"Bunjes D, Heit W, Arnold R et al. Evidence for the involvement of host-derived OKT8 positive T cells in the rejection of T-depleted HLA-identical bone marrow grafts Transplantation 1987 43: 501\u2013505","journal-title":"Transplantation"},{"key":"BF1702165_CR36","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1365-2141.1988.tb07628.x","volume":"9","author":"J Apperley","year":"1988","unstructured":"Apperley J, Mauro F, Goldman J et al. Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: importance of a graft-versus-leukaemia effect BrJ Haematol 1988 9: 239\u2013234","journal-title":"BrJ Haematol"},{"key":"BF1702165_CR37","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1097\/00007890-198804000-00018","volume":"45","author":"G Hale","year":"1988","unstructured":"Hale G, Cobbold S, Waldmann H . T-cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation Transplantation 1988 45: 753\u2013757","journal-title":"Transplantation"},{"key":"BF1702165_CR38","first-page":"264","volume":"22","author":"S Slavin","year":"1986","unstructured":"Slavin S, Or R, Naparstek E et al. New approaches for the prevention of graft-versus-host disease in clinical bone marrow transplantation Isr J Med Sci 1986 22: 264\u2013267","journal-title":"Isr J Med Sci"},{"key":"BF1702165_CR39","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1365-2141.1986.tb05544.x","volume":"63","author":"J Patterson","year":"1986","unstructured":"Patterson J, Prentice H, Brenner M et al. Graft rejection following HLA-matched T-lymphocyte depleted bone marrow transplantation Br J Haematol 1986 63: 221\u2013225","journal-title":"Br J Haematol"},{"key":"BF1702165_CR40","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1182\/blood.V92.12.4581","volume":"92","author":"G Hale","year":"1998","unstructured":"Hale G, Zhang M-J, Bunjes D et al. Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection Blood 1998 92: 4581\u20134590","journal-title":"Blood"},{"key":"BF1702165_CR41","doi-asserted-by":"crossref","unstructured":"Cull G, Haynes AP, Byrne JL et al. Allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-Campath conditioning Br J Haematol 2000 (in press)","DOI":"10.1046\/j.1365-2141.2000.01879.x"},{"key":"BF1702165_CR42","first-page":"336a","volume":"21","author":"H Baurmann","year":"1998","unstructured":"Baurmann H, Schimmelpfennig C, Brauninger S et al. ATG as part of the conditioning in matched unrelated (MUD) BMT Bone Marrow Transplant 1998 21: (Suppl. 1) 336a","journal-title":"Bone Marrow Transplant"},{"key":"BF1702165_CR43","first-page":"406a","volume":"21","author":"A Vitek","year":"1998","unstructured":"Vitek A, Sajdova J, Hrabenek J et al. ATG reduces the risk of severe aGVHD in MUD or haploidentical BMT Bone Marrow Transplant 1998 21: (Suppl. 1) 406a","journal-title":"Bone Marrow Transplant"},{"key":"BF1702165_CR44","first-page":"679a","volume":"24","author":"M Stockschlader","year":"1996","unstructured":"Stockschlader M, Kruger W, Betke R et al. ATG as part of the pre-transplant conditioning regimen reduces transplant-related mortality in CML patients undergoing allogeneic transplantation Exp Hematol 1996 24: 679a","journal-title":"Exp Hematol"},{"key":"BF1702165_CR45","first-page":"411a","volume":"21","author":"E Lanino","year":"1998","unstructured":"Lanino E, Locatelli F, Porta C et al. Pre-transplant ATG vs Campath IG for GVHD prophylaxis in pediatric recipients of unrelated BMT. An AIEOP-GITMO retrospective analysis of 112 patients Bone Marrow Transplant 1998 21: (Suppl. 1) 411a","journal-title":"Bone Marrow Transplant"},{"key":"BF1702165_CR46","first-page":"655a","volume":"24","author":"S Kato","year":"1996","unstructured":"Kato S, Kodera Y, Nagao T et al. Effect of ATG in conditioning for unrelated BMT on GVHD prophylaxis. A preliminary report of prospective cooperative study in Japan Exp Haematol 1996 24: 655a","journal-title":"Exp Haematol"},{"key":"BF1702165_CR47","doi-asserted-by":"publisher","first-page":"105a","DOI":"10.1038\/sj.bmt.1701047","volume":"21","author":"E Holler","year":"1998","unstructured":"Holler E, Ledderose G, Knabe H et al. ATG serotherapy during pre-transplant conditioning in unrelated donor BMT: dose-dependent modulation of GVHD Bone Marrow Transplant 1998 21: (Suppl. 1) 105a","journal-title":"Bone Marrow Transplant"},{"key":"BF1702165_CR48","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3109\/10428199309148532","volume":"9","author":"E Estey","year":"1993","unstructured":"Estey E, Plunkett W, Ghandi V et al. Fludarabine and arabinosylcytosine therapy of refractory and relapsed acute myelogenous leukemia Leuk Lymphoma 1993 9: 343\u2013350","journal-title":"Leuk Lymphoma"},{"key":"BF1702165_CR49","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1365-2141.1985.tb07383.x","volume":"60","author":"G Hale","year":"1985","unstructured":"Hale G, Swirsky D, Waldmann H, Chan L . Reactivity of rat monoclonal antibody CAMPATH-1 with human leukaemia cells and its possible application for autologous bone marrow transplantation Br J Haematol 1985 60: 41\u201348","journal-title":"Br J Haematol"},{"key":"BF1702165_CR50","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/00007890-199901270-00028","volume":"67","author":"NH Russell","year":"1999","unstructured":"Russell NH, Warwick R, Goldman J . Peripheral blood stem cells from unrelated donors for allogeneic transplantation Transplantation 1999 67: 339\u2013340","journal-title":"Transplantation"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1702165","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T21:52:44Z","timestamp":1648072364000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1702165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,2,1]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,2,1]]}},"alternative-id":["BF1702165"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1702165","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,2,1]]},"assertion":[{"value":"9 August 1999","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 1999","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2000","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}